Revenue: The sum of all revenue fields included for a company's operating activities.
Eli Lilly and Company (LLY) had Revenue of $24.40B for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$24.40B |
$6.45B |
|
$3.93B |
|
$20.46B |
|
$15.49B |
|
$8.91B |
|
$-505.00M |
|
$8.41B |
|
$8.71B |
|
$6.45B |
|
$6.45B |
|
$6.45B |
|
$6.82B |
|
$8.91B |
|
$9.46B |
|
891.90M |
|
893.40M |
|
$7.23 |
|
$7.22 |
|
| Balance Sheet Financials | |
$65.26B |
|
$32.19B |
|
$82.81B |
|
$148.07B |
|
$47.00B |
|
$46.99B |
|
$60.80B |
|
$107.80B |
|
$40.27B |
|
$12.31B |
|
$40.27B |
|
946.20M |
|
| Cash Flow Statement Financials | |
$27.42B |
|
$-27.61B |
|
$-2.26B |
|
$7.27B |
|
$4.88B |
|
$-2.38B |
|
$562.00M |
|
$-4.63B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.39 |
|
-- |
|
-- |
|
0.54 |
|
1.23 |
|
83.88% |
|
36.52% |
|
36.52% |
|
-- |
|
34.46% |
|
26.44% |
|
$18.98B |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.22 |
|
0.97 |
|
93.08 |
|
16.02% |
|
52.39% |
|
4.36% |
|
7.39% |
|
$42.56 |
|
$21.25 |
|
$30.69 |
|